BioAge Labs (BIOA) Operating Expenses (2023 - 2026)

BioAge Labs has disclosed Operating Expenses across 4 years of filings, most recently posting $28.1 million for Q1 2026.

• Operating Expenses for Q1 2026 came in at $28.1 million, up 57.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $112.0 million (up 34.52% YoY), and the FY2025 annual result was $101.8 million, up 30.16% from the prior year.
• Operating Expenses came in at $28.1 million for Q1 2026 at BioAge Labs, down from $31.5 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $31.5 million in Q4 2025 to a low of $9.9 million in Q3 2023.
• The 4-year median for Operating Expenses is $24.8 million (2024), against an average of $21.1 million.
• Across the five-year window, Operating Expenses surged 150.33% in 2024 and rose 1.79% in 2025, its largest moves.
• BioAge Labs' Operating Expenses stood at $13.6 million in 2023, then surged by 86.54% to $25.4 million in 2024, then gained by 24.21% to $31.5 million in 2025, then fell by 10.65% to $28.1 million in 2026.
• The last three Operating Expenses figures came in at $28.1 million (Q1 2026), $31.5 million (Q4 2025), and $25.2 million (Q3 2025), per Business Quant data.